日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy of Neratinib-Based Therapy in ERBB2-Mutant Lung Adenocarcinomas: Findings From 2 International Phase 2 Studies

奈拉替尼治疗ERBB2突变型肺腺癌的疗效:两项国际II期研究的结果

Li, Bob T; Gandhi, Leena; Ravichandran, Vignesh; Besse, Benjamin; Mazières, Julien; Shapiro, Geoffrey I; Boni, Valentina; Waqar, Saiama N; Park, Haeseong; Quinn, David I; Martinez, Alejandro; Stemmer, Salomon M; Cortot, Alexis B; Barlesi, Fabrice; Quoix, Elisabeth; Burkard, Mark E; Selcuklu, S Duygu; Hunt, Casey; Donoghue, Mark T A; Kris, Mark G; Bebchuk, Judith; Eli, Lisa D; McCulloch, Leanne; Solit, David B; Jänne, Pasi A

IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer

IFCT-1502 CLINIVO:一项全国性晚期非小细胞肺癌患者队列研究,提供了纳武利尤单抗治疗长期生存的真实世界证据

Molinier, O; Besse, B; Barlesi, F; Audigier-Valette, C; Friard, S; Monnet, I; Jeannin, G; Mazières, J; Cadranel, J; Hureaux, J; Hilgers, W; Quoix, E; Coudert, B; Moro-Sibilot, D; Fauchon, E; Westeel, V; Brun, P; Langlais, A; Morin, F; Souquet, P J; Girard, N

1260MO Activity of OSE-2101 in HLA-A2+ non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (ICI): Step 1 results of phase III ATALANTE-1 randomised trial

1260MO OSE-2101 在 HLA-A2+ 非小细胞肺癌 (NSCLC) 患者中免疫检查点抑制剂 (ICI) 治疗失败后的活性:III 期 ATALANTE-1 随机试验的第一阶段结果

Pradier, A; Mamez, A C; Stephan, C; Giannotti, F; Masouridi-Levrat, S; Wang, S; Morin, S; Neofytos, D; Vu, D L; Melotti, A; Arm, I; Eberhardt, C S; Tamburini, J; Kaiser, L; Chalandon, Y; Simonetta, F; Bakouny, Z; Grover, P; Labaki, C; Awosika, J; Gulati, S; Hsu, C-Y; Bilen, MA; Eton, O; Fecher, L; Hwang, C; Khan, H; McKay, RR; Ruiz, E; Weissmann, L; Thompson, MA; Shah, D; Warner, J; Shyr, Y; Choueiri, TK; Wise-Draper, T; Pacheco-Barcia, V; Sanchez, DA; Obispo, B; Quilez, A; Sesma, A; JimEnez Labaig, P; Paez, D; Quintanar Verduguez, T; Sánchez Cánovas, M; Tarazona, N; Fernandez Montes, A; Felip, E; Rodríguez-Lescure, A; Elez Fernandez, ME; Giaccone, G; Felip, E; Cobo, M; Campelo, R Garcia; DENIS, F; Quoix, E; Madroszyk, A; Debieuvre, D; Hilgers, W; Moran, T; Galetta, D; Romano, GD; Cappuzzo, F; Robinet, G; Masson, P; Viteri, S; Peled, N; Costantini, D; Dziadziuszko, R; Besse, B

Development and Validation of a Simplified Prognostic Score in SCLC

小细胞肺癌简化预后评分的开发与验证

Negre, Elodie; Coffy, Amandine; Langlais, Alexandra; Daures, Jean-Pierre; Lavole, Armelle; Quoix, Elisabeth; Molinier, Olivier; Greillier, Laurent; Audigier-Valette, Clarisse; Moro-Sibilot, Denis; Westeel, Virginie; Morin, Franck; Roch, Benoît; Pujol, Jean-Louis

Should we screen patients for carotid artery disease before lung cancer resection?

我们是否应该在肺癌切除术前对患者进行颈动脉疾病筛查?

Charloux, Anne; Matau, Cézar; Jégu, Jérémie; Rouyer, Olivier; Falcoz, Pierre-Emmanuel; Quoix, Elisabeth

Role of the YAP-1 Transcriptional Target cIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients with Tumor RASSF1A Gene Methylation from the Phase 3 IFCT-0002 Trial

YAP-1 转录靶标 cIAP2 在 3 期 IFCT-0002 试验中肿瘤 RASSF1A 基因甲基化非小细胞肺癌 (NSCLC) 患者对化疗的差异敏感性中的作用

Fatéméh Dubois, Maureen Keller, Julien Hoflack, Elodie Maille, Martine Antoine, Virginie Westeel, Emmanuel Bergot, Elisabeth Quoix, Armelle Lavolé, Laurence Bigay-Game, Jean-Louis Pujol, Alexandra Langlais, Franck Morin, Gérard Zalcman, Guénaëlle Levallet

Ceritinib-related interstitial lung disease improving after treatment cessation without recurrence under either crizotinib or brigatinib: a case report

一例塞瑞替尼相关间质性肺病患者停药后病情改善,且在克唑替尼或布加替尼治疗下均未复发:病例报告

Bender, Laura; Meyer, Guillaume; Quoix, Elisabeth; Mennecier, Bertrand

Phase II study assessing the benefit of cisplatin re-introduction (stop-and-go strategy) in patients with advanced non-squamous non-small cell lung cancer: the IFCT-1102 BUCiL study (a Better Use of Cisplatin in Lung cancer)

一项 II 期研究评估了在晚期非鳞状非小细胞肺癌患者中重新引入顺铂(停用策略)的益处:IFCT-1102 BUCiL 研究(更好地利用顺铂治疗肺癌)

Bennouna, Jaafar; Barlesi, Fabrice; Do, Pascal; Dumont, Patrick; Cadranel, Jacques; Debieuvre, Didier; Hilgers, Werner; Molinier, Olivier; Quoix, Elisabeth; Raimbourg, Judith; Langlais, Alexandra; Morin, Franck; Souquet, Pierre-Jean

Time to give a rest to cetuximab in the treatment of advanced non-small cell lung carcinoma?

是否应该暂停使用西妥昔单抗治疗晚期非小细胞肺癌?

Quoix, Elisabeth; Westeel, Virginie

Lung segmentectomy: does it offer a real functional benefit over lobectomy?

肺段切除术:与肺叶切除术相比,它真的能带来功能性益处吗?

Charloux, Anne; Quoix, Elisabeth